内源性哮喘免疫支持治疗的探讨

Discussion of immutheropy to patients with intrinsic asthma

目的探讨免疫支持治疗在内原性支气管哮喘的作用。方法分别检测40例内源性支气管哮喘患者及正常对照组的TH1、TH2值。结果内源性支气管哮喘患者TH1下降(P<0.05),免疫支持治疗效果较好。结论TH1/TH2比例失衡是引起和诱发哮喘的主要因素之一,免疫支持治疗对内源性支气管哮喘治疗效果较好,可以作为较长期治疗的重要手段。

[Objective] To discuss the effects of immutheropy to patients with intrinsic asthma. [Methods] The TH1, TH2 of 40 patients with intrinsic asthma and 40 normals were examined by Elisa. [Results] The TH1 of patients with intrinsic asthma was lower than the normal group （P 〈0.05）. [Conclusion] The rate of TH1/TH2 is one of main factors in asthma. It is better to the patients with intrinsic asthma to use immutheropy than other methods.